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ABSTRACT
Background: Amyotrophic lateral sclerosis (ALS) is a degenerative motor neuron 
disease leading to progressive muscle weakness resulting in respiratory failure 
and death. The average survival time from diagnosis is two to three years. The use 
of tracheostomy invasive ventilation (TIV) may, however, prolong life by several 
years. ALS has a major impact on the lives of both the patients and their next of kin/
informal care givers. There is no cure for ALS and the cornerstone of  management 
is symptomatic treatment to alleviate symptoms and improve health-related quality 
of life (HRQL).
Aims: The aims of this thesis were to explore aspects of disability, contextual fac-
tors and HRQL in patients with ALS, and to explore the caregiving experiences and 
HRQL in their next of kin/informal caregivers. In addition, this thesis aimed to 
investigate the experiences of being next of kin to patients with ALS undergoing TIV. 
Material and methods: Sixty patients with ALS were included at baseline (Study I) 
and followed-up every 6 months for three years, unless participants had deceased 
or declined participation (Study II). Data on disability, contextual factors and 
HRQL were collected from medical records, and by study-specific protocols and 
standardized questionnaires administrated during home visits. Forty-nine next of 
kin/informal caregivers to patients with ALS were included to explore  caregiving 
experience, HRQL and life satisfaction (Study III). Data were collected by study-
specific protocols and standardized questionnaires. Multivariate regression analy-
ses were used to explore factors associated with patients’ HRQL (Study I) and 
informal caregivers’ HRQL and life satisfaction (Study III). Descriptive statistics 
and correlation analyses were used to present and explore data on disability and 
contextual factors over three years (Study II). Eight next of kin were included to 
investigate the experiences of being next of kin to patients with ALS  undergoing 
TIV (Study IV). Semi-structured face-to-face interviews were conducted and ana-
lyzed with qualitative content analysis with an inductive approach.
Results: Regardless of disease severity, fatigue, anxiety, depression and pain were 
commonly and concurrently present in patients with ALS. Furthermore, activity 
limitations and participation restrictions were frequently reported. The health con-
dition, i.e. high disease severity; the impairments fatigue, anxiety and/or depres-
sion; participation restrictions, i.e. low frequency of social and life style activities; 
and the contextual factors weak coping capacity and mechanical ventilator use 
(non-invasive and TIV) were associated with worse HRQL in patients with ALS. 
Both positive and negative caregiver experiences were reported by the informal 
caregivers. Positive experience and older age in the informal caregiver were 
associated with better HRQL, while negative caregiving experiences and  anxiety 
and/or depression in the patient with ALS were associated with worse HRQL in 
informal caregivers. As for life satisfaction, older age in the informal caregiver and 
not cohabiting with the patient were associated with being satisfied with “life as a 
whole”. Being next of kin to patients with ALS undergoing TIV involved experi-
ences of a turbulent care process aiming to extend life, a struggle to cope with the 
strains of everyday life, and of conflicting roles as next of kin and carer.
Conclusion: Patients with ALS need, throughout the course of the disease, to be 
regularly screened for commonly present impairments, activity limitations, partici-
pation restrictions and perceived HRQL, so that person-centred care can be applied 
at the right time. There is a need to consider the individual caregiver’s experience 
when planning services, care and support. Furthermore, it is important to adopt 
person-centred care, not only for patients but also for their informal caregivers, as 
factors related to both parties were associated with the informal caregivers’ HRQL 
and life satisfaction. It is important to involve next of kin to patients with ALS 
undergoing TIV throughout the whole care process, and to consider the specific 
needs of the next of kin. Furthermore, specific support interventions for next of 
kin to facilitate their everyday life and to ease their burden need to be developed.
SAMMANFATTNING
Bakgrund: Amyotrofisk lateral skleros (ALS) är en degenerativ motorneuron-
sjukdom som leder till progressiv muskelsvaghet vilket resulterar i respiratorisk 
svikt och att den drabbade avlider. Den genomsnittliga överlevnadstiden efter 
diagnos är två till tre år. Genom invasiv ventilation via trakeostomi (TIV) kan dock 
livet förlängas med flera år. ALS har en stor inverkan på livet för både patienterna 
och deras närstående/informella vårdgivare. Det finns inget botemedel mot ALS 
och det grundläggande för hälso- och sjukvården är symptomatisk behandling för 
att lindra symptom och förbättra hälso-relaterad livskvalitet (HRQL).
Syfte: Det övergripande syftet med avhandlingen var att utforska  funktionshinder, 
kontextuella faktorer och HRQL hos patienter med ALS, och att utforska vårdgivar-
erfarenheter och HRQL hos deras närstående/informella vårdgivare. Dessutom var 
syftet att undersöka erfarenheter av att vara närstående till patienter med ALS 
som har TIV.
Material och metod: Sextio patienter med ALS inkluderades vid baslinjen (Studie I) 
och följdes sedan var sjätte månad under tre år, med undantag för de patienter som 
hade avlidit eller avböjt deltagande i studien (Studie II). Data gällande funktions-
hinder, kontextuella faktorer och HRQL samlades in från medicinska journaler, 
studie specifika protokoll och standardiserade frågeformulär vid hembesök. Fyrtionio 
närstående/informella vårdgivare till patienter med ALS inkluderades för att utforska 
vårdgivarerfarenheter, HRQL och livstillfredsställelse (Studie III). Data samlades 
in med studiespecifika protokoll och standardiserade frågeformulär. Multivariata 
regressionsanalyser användes för att utforska faktorer som hade samband med 
patienternas HRQL (Studie I) och informella vårdgivares HRQL och livstillfreds-
ställelse (Studie III). Beskrivande statistik och korrelations analyser användes för 
att presentera och utforska data om funktionshinder och kontextuella faktorer 
(Studie II). Åtta närstående inkluderades för att undersöka erfarenheterna av att 
vara närstående till patienter med ALS som har TIV (Studie IV). Semi-strukturerade 
intervjuer genomfördes och analyserades med kvalitativ innehållsanalys med 
induktiv ansats.
Resultat: Oavsett sjukdomsgrad så var fatigue, ångest, depression och smärta 
vanligt och samtidigt förekommande hos patienter med ALS. Dessutom var 
aktivitetsbegränsningar och delaktighetsinskränkningar frekvent förekommande. 
Hälsotillståndet, d.v.s. hög sjukdomsgrad; funktionsnedsättningarna fatigue, ångest 
och/eller depression; delatighetsinskränkning, d.v.s. låg frekvens av sociala och 
livsstilsrelaterade aktiviteter; och de kontextuella faktorerna svag copingförmåga 
och mekanisk ventilation (icke-invasiv och TIV) hade ett samband med sämre 
HRQL hos patienter med ALS. Både positiva och negativa vårdgivarerfarenheter 
rapporterades från informella vårdgivare. Positiva erfarenheter och högre ålder 
hos den informella vårdgivaren hade ett samband med bättre livskvalitet, medan 
negativa erfarenheter och ångest och/eller depression hos patienten med ALS hade 
ett samband med sämre HRQL. Gällande livstillfredsställelse, så hade högre ålder 
hos den informella vårdgivaren och att inte sammanbo med patienten ett samband 
med att vara tillfredsställd med ”livet som helhet”. Att vara närstående till patienter 
med ALS som har TIV innefattar erfarenheter av en turbulent vårdprocess med 
syfte att förlänga livet, att kämpa för att hantera ett ansträngt vardagsliv och kon-
flikten i rollerna att vara både närstående och vårdare.
Konklusion: Patienter med ALS behöver, under hela sjukdomsförloppet, regel-
bundet undersökas för vanligt förekommande funktionsnedsättningar, aktivitets-
begränsningar, delatighetsinskränkningar och upplevd HRQL så att personcentrerad 
vård kan implementeras vid rätt tidpunkt. Den informella vårdgivarens erfaren heter 
behöver tas i beaktande när service, vård och stöd planeras. Dessutom är det viktigt 
att anpassa den personcentrerade vården, inte bara riktat till patienter utan även till 
deras informella vårdgivare, eftersom faktorer relaterade till båda parter hade ett 
samband med informella vårdgivares HRQL och livstillfredsställelse. Det är vik-
tigt att närstående till patienter med ALS som har TIV är involverade genom hela 
vårdprocessen och att deras specifika behov beaktas. Vidare behöver särskilda stöd-
insatser utvecklas för att underlätta närståendes vardagsliv och minska deras börda.
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11 INTRODUCTION
1.1 Amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is an adult-onset motor neuron disease that 
primarily affects upper and lower motor neurons in the motor cortex, brainstem 
and spinal cord, leading to progressive weakness and wasting in voluntary muscles, 
and eventually resulting in respiratory failure and death. Cognitive and behavioural 
impairments are today considered to be present in ALS (1), and there is, reportedly, 
an overlap between ALS and frontotemporal dementia (2, 3). Other examples 
of motor neuron diseases related to ALS are primary lateral sclerosis with pure 
involvement of upper motor neurons and progressive muscle atrophy with pure 
lower motor neuron involvement (2).
The incidence rate of ALS in European populations is approximately 3 per 100,000 
person-years (4, 5). The disease is more common in men than in women, and 
the reported male and female incidence is 3.1 and 2.2 per 100,000 person-years, 
respectively (6). Most cases of ALS are sporadic, and around 5-10% are familial 
(hereditary) (2). Peak age at onset is 58-63 years for sporadic ALS and 47-52 years 
for familial (7). Occurrence of the disease declines rapidly after 80 years of age (6).
There is no biological marker for ALS, and diagnosis is based on the revised 
El Escorial criteria (8). These criteria require evidence of both upper and lower 
motor neuron degeneration in combination with a progressive spread of symptoms 
and signs in the absence of electrophysiological, pathological and neuroimaging 
evidence of other disease processes (8). ALS can, based on levels of certainty, be 
categorized as definite, probable, possible or suspected ALS (8).
Depending on the site of onset, ALS is often classified as spinal (limb muscles) or 
bulbar (speech and swallowing muscles) form. Most common is the spinal form, 
and spinal onset is reported in 80% of patients (9). The average survival time 
from diagnosis is two to three years, although some patients with ALS will live 
for decades (10). Younger age at onset (10), male sex and spinal onset have been 
found to be predictors of longer survival (9, 10).
There is a high number of different mutations and variable penetrance of genes 
causing familial ALS (2). Most common are mutations in the C9orf72 (11) and 
SOD1 (12) genes. The causes of sporadic ALS are of unknown aetiology. Suggested 
potential risk factors for ALS are the environmental factor smoking and the personal 
factors older age and male sex (13).
21.2 International classification of functioning, disability 
and health
The International Classification of Functioning, Disability and Health (ICF) (14) 
is used in the present thesis as a conceptual framework for describing and explor-
ing functioning, disability and contextual factors in patients with ALS and their 
next of kin. The interactions between the components of the ICF are described 
in Figure 1 (14). 
The ICF was developed by the World Health Organization (WHO) and provides a 
framework for the scientific structure of functioning, disability and health in indi-
viduals or groups of people. The ICF provides a common language for describing 
health and enables comparisons of data in a scientific context. In the ICF, health 
condition is an umbrella term for a disease (such as ALS), disorder, injury or trauma. 
The ICF classifies information in two parts, each containing two components. 
The first part pertains to functioning and disability. Functioning is an overarching 
term that refers to body functions and body structures, as well as to activities and 
participation. The term disability describes impairments in body functions and 
body structures, as well as limitations in activities and restrictions in participation. 
The second part addresses contextual factors, including distinctions between per-
sonal and environmental factors. Personal factors are individual characteristics, 
such as age, sex, education and ability to cope. Personal factors are not classified 
in the ICF. Environmental factors are aspects of the physical, social and attitudinal 
environment in which a person lives. These factors are outside the person and can 
either facilitate or hinder functioning and disability (14). Products and technology, 
e.g. medicines and aids for use in daily living, mobility and communication; sup-
port and relationships, e.g. from family, personal care providers, personal assistants 
and health professionals; and services, systems and policies are all examples of 
environmental factors.
Body functions & 
structures (impairments)
Activities 
(limitations)
Participation 
(restrictions)
Health condition
Environmental factorsPersonal factors
Figure 1. Interactions between components of the ICF.
31.3 Disability in ALS
1.3.1 Impairments in body functions and structures
Common impairments in patients with ALS due to the process of upper motor 
neuron degeneration are spasticity, progressive weakness and brisk tendon reflexes 
in limbs (2). Degeneration of lower motor neuron typically presents signs of 
fasciculation, wasting and progressive weakness in muscles (2). Bulbar motor 
neuron degeneration causes dysarthria (15) and dysphagia (16). The latter leads 
to weight loss and malnutrition. Other reported impairments are thickened saliva 
and hypersalivation (2). 
The earlier view of ALS as a pure motor neuron disease has been challenged, 
as studies have shown that approximately 35% of ALS patients have cognitive 
impairment and an additional 15% fulfil the criteria for frontotemporal dementia 
(17, 18). Reported behavioural changes are apathy (1, 19, 20), irritability (19), 
loss of empathy, perseveration and disinhibition (1). 
Fatigue (21, 22), anxiety (23, 24), depression (22, 24) and pain (25, 26) are other 
reported impairments in patients with ALS. Fatigue has been found in approxi-
mately 40% to 50% of patients (21, 22) and is reported to be associated with dis-
ease severity (21, 22). Anxiety has been reported in 19% to 35% of patients (27, 
28) and depression in 22% to 36% (22, 28). Patients with ALS have scored worse 
than the general population on anxiety and depression measures (29); however, 
neither anxiety nor depression have been found to be associated with disease 
severity (23). Approximately 40% to 70% of patients with ALS experience pain 
(25, 30, 31), which is a greater share than has been found for compared controls 
(25, 31). The variation in reported pain frequency is probably due to differences 
in studied patient groups and in the methods used. The relation between pain and 
disease severity is contradictory, as both an association and a lack of association 
have been reported (25, 26). The variations in reported frequencies of the above-
mentioned impairments might be due to differences in small and heterogeneous 
samples and in the methods used.
1.3.2 Activity limitations and participation restrictions
A loss of independence in activities of daily living (ADL) is reported in patients with 
ALS, for example, in eating and drinking, toileting, dressing, cleaning or shopping 
(32). Studies have reported that both activity limitations and participation restric-
tions, e.g. in social and lifestyle activities such as domestic chores, work, leisure 
and outdoor activities, are common (33, 34). Communication limitations due to 
dysarthria and various neuropsychiatric disturbances are reported in patients with 
ALS (35). Speech intelligibility is reported to decline over time and is associated 
with a limitation in communication effectiveness (36).
41.4 Contextual factors in ALS
1.4.1 Personal factors
Personal factors such as age, sex and body mass index (BMI) are important to 
consider when describing ALS. Older age, male sex and a family history of ALS 
(37) are risk factors for ALS. Greater physical fitness, but not muscle strength, 
at age 18 years is also associated with a higher risk of ALS (38). Furthermore, 
low BMI and high BMI reduction rates are reported to be associated with shorter 
survival (39-41).
An important personal factor is the ability to handle or cope with stressful situa-
tions in life (42). Individuals with a poor ability to cope when living with a disease 
may experience increased disability (43). Studies report that patients with ALS use 
both problem-focused and emotion-focused strategies and that coping strategies 
change during the course of the disease (44, 45). Sense of coherence, as described 
by Antonovsky (42), is one way of looking at coping ability and has been used in 
a number of studies of people with chronic conditions (46-49). Sense of coherence 
describes whether individuals see their existence as meaningful, comprehensible 
and manageable, and individuals with a stronger sense of coherence are more likely 
to cope with stressful situations (42). Studies on coping ability as measured with 
sense of coherence in patients with ALS have not yet been published.
1.4.2 Environmental factors
Environmental factors can be either facilitators or barriers in ALS management. 
Medical treatment, aids and services are described as potential facilitators (2), 
while lack of the above mentioned may be considered potential barriers.
Riluzole is today the only registered disease modifying therapy in Sweden and is 
reported to increase the median survival time by two to three months (50). Medical 
symptomatic treatments for anxiety, depression, insomnia, fatigue, cramps, spasticity 
and hypersalivation are recommended (51). To facilitate mobility, including walk-
ing and moving around, orthoses and aids such as walking sticks and wheelchairs 
are recommended, as are aids to facilitate ADL, communication, ventilation and 
nutrition (2). 
Specialized multidisciplinary care with collaboration between various health pro-
fessionals is recommended for patients with ALS (52) and is usually provided for 
patients in Sweden. Besides improving health-related quality of life (HRQL) (52), 
multidisciplinary care can reduce the number of hospital admissions and days in 
hospital (53), and prolong survival (54). 
5To reduce impact of disability, regardless of illness, all Swedish citizens have the 
opportunity to apply for transportation services and for home care services and 
personal assistance.
Respiratory insufficiency is to be treated through health care (51), and, in addition 
to physiotherapy treatment, mechanical ventilation is used. The primary option 
is commonly non-invasive ventilation, i.e. treatment by air pressure thru a fascial- 
or nasal mask (51). Non-invasive ventilation is found to alleviate symptoms of 
respiratory insufficiency and, to some extent, increase survival (55-58). Less 
common is tracheostomy invasive ventilation (TIV), i.e. treatment by air pressure 
through a tracheostomy tube. TIV is currently the only way to prolong life by years 
in patients with ALS (59, 60). The disease will, however, still progress with the 
risk of the patient developing a “locked-in” state (51). After receiving TIV, most 
patients live in their home (59, 61).
Treatment with TIV varies between countries, reportedly from 0-11% in Europe 
and the USA (59, 62, 63) to 30% in Japan (64). Initiation of TIV is influenced by 
uncertainties of its impact on patients’ quality of life (QoL) (51), the economic 
means to maintain the treatment (64, 65), and the attitudes of physicians (66), 
patients (67) and their next of kin (68). Since 2010, the Karolinska University 
Hospital clinical guidelines state that TIV should be considered when non-invasive 
ventilation is insufficient. Approximately 8% of patients with ALS in Stockholm 
County undergo TIV today (69).
1.5 Next of kin to patients with ALS
In addition to the support provided by society, there is an increased need for infor-
mal care, i.e. unpaid care, during the course of the disease (32). Internationally, it has 
been reported that next of kin to patients with ALS assume a great responsibility 
for this informal care (70, 71), and both the amount of time spent on informal 
care and the burden of caregiving are reported to be substantial (72-74). Studies 
show that next of kin spend approximately 50-60 hours per week on caregiving 
(70, 74) and that time spent on informal care is associated with high self-reported 
caregiver burden (70). Reported factors modulating caregiver burden are the care-
giver’s age, employment status and social support (70); and the patients’ cognitive 
impairments (73) and behavioural changes (73, 75). Caregiving is described as a 
multi-faceted construct with both positive and negative experiences (76), though 
only a few studies explore both the positive and negative sides of caregiving in 
next of kin to patients with ALS (77, 78). 
6The experiences of next of kin to patients with ALS undergoing non-invasive ven-
tilation are found to be both positive and negative (79, 80), e.g. feelings of stress 
and relief, which alternate during the course of the disease (81). It is also reported 
that as the ALS disease progresses, it causes an increased emotional burden on 
the next of kin (70, 80). 
Big differences are reported in studies (68, 82) on the attitudes next of kin hold 
toward TIV as a treatment option for family members with ALS. It is reported that 
5% to 53% of next of kin are in favour of and that 10% to 86% are opposed to TIV 
as a treatment option (68, 82). The results are based on investigations conducted in 
the USA (68, 82)  and in Japan (68), and show that a much more positive attitude 
towards TIV is held by next of kin from Japan than from in the USA. Different 
cultures and different attitudes among health care professionals, e.g. different ways 
of presenting opportunities to receive TIV, may have influenced the discrepancy 
of the results. Important factors contributing to whether next of kin are in favour 
of TIV are that the use gives hope for the future and that the family member with 
ALS can maintain their QoL. Next of kin to patients with ALS using TIV express 
that they must spend more time on care than they wish to, and that they experi-
ence health problems and are unable to hold salaried jobs (83). Also reported are 
feelings of having to give up their own lives and loss of control over their own 
life situations (84).
1.6 HRQL and life satisfaction
Even though the ICF provides a framework for obtaining a comprehensive view 
of an individual’s functioning, disability and health, it lacks a reference to QoL, 
which is needed to make a complete description of an individual’s health status. 
QoL is described as a multi-dimensional construct (85), but there is little con-
sensus in the literature on what should be included in the construct. The WHO 
defines QoL as “an individual’s perception of their position in life in the context 
of the culture and value systems in which they live and in relation to their goals, 
expectations, standards and concerns” (86). Further, QoL is described as a broad 
ranging construct affecting the psychological states, physical health, social rela-
tions and beliefs of individuals and their relationship to prominent features of the 
environment in complex structures (86). 
The concept of HRQL is often used in medicine to distinguish between QoL in a 
more general sense and aspects of QoL that are concerned with functioning and 
well-being in relation to illness and its treatment (87). Questionnaires on HRQL 
generally reflect the multi-dimensional construct of QoL and focus on items covering 
physical, emotional (mental) and social functioning, as well as general health (88). 
7Life satisfaction is described as a measure of happiness (89). By mobilizing 
resources within an individual, that individual may achieve optimal life satisfac-
tion (90). Life satisfaction is generally agreed to be part of the multi-dimensional 
construct of QoL (88). In this thesis, life satisfaction is used as a complement to 
HRQL in next of kin to patients with ALS to cover aspects other than HRQL.
1.6.1 HRQL in patients with ALS
Patients with ALS rate their HRQL worse than a general population (29), and it 
is reported that patients’ HRQL become worse with increasing disease severity 
(91). The physical dimension of HRQL is found to deteriorate during the course 
of the disease while the mental dimension remains stable (23, 92). Impairments 
like fatigue (93), anxiety (94), depression (93, 95, 96) and pain (97) are reported 
to worsen HRQL. A strong ability to cope when living with a deadly disease like 
ALS (98, 99) is associated with better HRQL. Mechanical ventilation is found to 
be associated with both better and worse HRQL (100-102).
1.6.2 HRQL in next of kin
It is important to consider the HRQL of the next of kin, as they often act as informal 
caregivers to family members with ALS as they become weaker, more dependent, 
and in need of increased care as the disease progresses (103). There is evidence 
that HRQL is negatively impacted in next of kin to patients with ALS (104, 105). 
Negative experiences of informal caregiving such as psychological distress and 
impact on relations are found to be associated with worse HRQL in next of kin 
(74). Others report that more time spent on informal caregiving (106), younger 
age, female gender (104) and presence of depression (75) among caregivers are 
factors associated with worse HRQL. In addition, factors related to patients with 
ALS are also associated with worse HRQL in next of kin, e.g. disease severity 
(94), inability to communicate (107), changes in behaviour (75) and TIV use (83, 
102), although the latter is less impacted if the patient has formal caregiving (102).
Life satisfaction has been reported to be associated with both positive and nega-
tive caregiving experiences in informal caregivers to patients with stroke (108, 
109). There are, however, few studies on life satisfaction in informal caregivers 
to patients with ALS (94), and we lack knowledge of factors associated with life 
satisfaction among informal caregivers to patients with ALS.
1.7 Rationale for the thesis
Although disability and contextual factors have previously been described in 
patients with ALS (21-23), few studies give a comprehensive view of concur-
rent body-function impairments, as well as activity limitations and participation 
8restrictions over time. There is no cure for ALS, and the cornerstone of manage-
ment is symptomatic treatment to alleviate symptoms and improve HRQL. Thus, 
it is important to investigate factors impacting patients’ HRQL, as some might be 
amenable to health-care interventions. 
ALS is a disease that not only affects patients but also their next of kin, who often 
become informal caregivers. It is therefore important to investigate their experi-
ences in caregiving, and factors related to their HRQL and life satisfaction, so that 
appropriate measures can be taken to develop support and care. 
The average survival time after diagnosis of ALS is two to three years. The use 
of TIV may, however, prolong life by several years, although the disease will still 
progress with a risk of the patient developing a “locked-in” state. As most patients 
live in their homes after receiving TIV, the life of next of kin is likely imposed 
upon. Studies investigating the experiences of next of kin to patients with ALS 
undergoing TIV are scarce (83, 84). Thus, there is an urgent need for such studies.
In summary, the knowledge gaps described above need to be addressed so that 
health care can develop interventions to meet the needs of patients with ALS and 
their next of kin.
92 AIMS
The overall aim of this thesis were to explore aspects of disability, contextual 
factors and HRQL in patients with ALS, and to investigate the experiences and 
HRQL in their next of kin.
The specific aims were:
1. To describe and explore the impact of disease severity, fatigue, anxiety, 
depression, frequency of social and lifestyle activities, coping capacity 
and mechanical ventilator use on HRQL in persons with ALS (Study I).
2. To describe and explore disease severity and impairments, activity limita-
tions, participation restrictions and contextual factors in patients with ALS 
over time. In particular, to explore concurrent presence of cognitive impair-
ment, fatigue, anxiety, depression and pain, and whether these impairments 
were related to disease severity in patients with ALS (Study II).
3. To describe caregiver experience, HRQL and life satisfaction among informal 
caregivers to patients with ALS, and to explore factors associated with care-
givers’ HRQL and life satisfaction (Study III).
4. To investigate the experience of being next of kin to patients with ALS 
undergoing TIV (Study IV).
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3 MATERIAL AND METHODS
3.1 Study designs
Studies I and III used cross-sectional designs, Study II a prospective observational 
design over three years, and Study IV a qualitative design.
3.2 Participants
3.2.1 Studies I and II
Figure 2 presents a flow chart of patient inclusion and retention in Studies I and II. 
In September 2012, 102 patients with ALS were identified through the Department 
of Neurology at the Karolinska University Hospital in Stockholm, Sweden. Inclusion 
criteria were an ALS diagnosis according to the El Escorial criteria; an age of over 
18 years; and the ability to understand Swedish. Sixty patients were enrolled in 
Study I, and they were contacted six months later and invited to participate in a 
follow-up study. The process of contacting the patients with ALS who were still 
included in the subject pool was then repeated prior to every additional six-month 
follow-up for two and a half years, i.e. in total, data was collected for three years, 
at baseline (T1) and at six follow-ups (T2 to T7).
3.2.2 Study III
Participants in Study III were identified by patients with ALS included in Study I. 
Of a total of 58 next of kin, 9 declined participation; thus, 49 were included in 
Study III.
3.2.3 Study IV
Next of kin participating in Study IV were recruited via patients with ALS who 
used TIV and were registered at an ALS clinic in Sweden. A total of 12 patients 
were identified in May 2017, and all but one were regarded suitable for contacting 
according to their neurologist. Six of the eleven patients who received information 
about the study identified one or more next of kin who were able to communicate 
in Swedish to be approached by the researchers. Included in Study IV were eight 
next of kin, three of whom were related to the same patient.
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Figure 2. A flowchart of the inclusion and retention of patients with ALS during the 
three-year study period.
T2, n=38
T1, n=60
T4, n=17
T7, n=12
T3, n=29
T5, n=14
T6, n=14
Lost to follow-up, n=1
Declined, n=14
Deceased, n=7
Declined, n=1
Deceased, n=1
Declined, n=2
Deceased, n=8
Lost to follow-up, n=1
Declined, n=4
Deceased, n=7
Lost to follow-up, n=2
Declined, n=1
Deceased, n=1
Declined, n=1
Deceased, n=1
Rejoined, n=1
Rejoined, n=1
Rejoined, n=2
Identified persons with
ALS, n=102 Excluded due to: 
Terminal stage, n=11
Dementia disease, n=5, 
Unable to speak
Swedish, n=4Terminal s
Declined participation, n=19 
Not answering invitation, n=3
Invited to participate, 
n=82
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3.3 Procedures
Data collection in Studies I and II were performed during home visits to patients 
with ALS by one of three physiotherapists or an occupational therapist who 
guided the patient through the data collection. The duration of each home visit 
was in average 2.5 hours, and extra visits were offered if needed. Data collection 
comprised study-specific protocols administered as interviews and self-reported 
standardized questionnaires in a standardized order. Patients could either fill out 
the questionnaires themselves or get help from the data collector. 
Data for Study III were collected by study-specific protocols and self-reported 
standardized questionnaires filled out by the next of kin, either during the home 
visits to the patient with ALS or later, i.e. they received the protocols and question-
naires and returned them to the data collector by post. 
Data for Study IV were collected through face-to-face interviews conducted by 
either a pair of registered physiotherapists or a registered physiotherapist and a 
registered nurse. Interviews were performed in a place chosen by the next of kin, 
most often in their home.
3.4 Measures (Studies I, II and III)
Medical records, study-specific protocols and self-reported standardized question-
naires were used to collect information from patients with ALS and their next of kin. 
See Table 1 for an overview of variables from medical records and study-specific 
protocols, and Table 2 for an overview of variables and self-reported standardized 
questionnaires that were used.
3.4.1 The ALS Functioning Rating Scale-Revised
The ALS Functioning Rating Scale-Revised (ALSFRS-R) was used as a proxy for 
disease severity in patients with ALS (110). The ALSFRS-R concerns impairments 
in gross motor tasks, fine motor tasks, bulbar functions and respiratory function. 
The scale consists of 12 items, each graded from 0 to 4. A total score ranging 
from 0 to 48 is calculated, and lower scores indicate more disease severity. The 
ALSFRS-R is considered valid (110) and reliable (111, 112).
In Study I, an ALSFRS-R score of ≤ 29 (median score) was used as the cut-off for 
severe disease. In Study II, disease severity was categorized as mild (ALSFRS-R 
score 37-48), moderate (ALSFRS-R score 25-36), and severe (ALSFRS-R score 
0-24), as previously suggested (113). In Study III, an ALSFRS-R score of ≤ 24 
(lower half of the scale) was used as cut-off for severe disease.
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Table 1. Overview of variables from medical records and  
study-specific protocols in Studies I, II and III.
Variable Study
I II III
Medical records
 Site of onset X X
 Time since diagnosis X X
 Medications X X
Study-specific protocol 
 Age X X X
 Sex X X X
 Education level X X X
 Living conditions X X
 Cohabiting with patient X
 Civil status X
 Relation to patient X
 Work status X X X
 Changed working time X
 Informal caregiving (hours/week) X
 Ventilation X X
 Gastrostomy X X
 Aid for
 Mobility X X X
 Activities of daily living X X X
 Communication X X X
 Home adaptations X X X
 Home care X X X
 Personal assistance X X X
 Transport service X X
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3.4.2 The Sense of Coherence Scale
The Sense of Coherence Scale (SOC) was used to assess coping capacity in 
patients with ALS (42). The SOC consists of 13 items, each graded from 1 to 7. 
A total score, ranging from 13 to 91, is calculated. The SOC is considered valid 
(114) and reliable (115).
In Studies I and III, a SOC score of ≤ 54  was used as the cut-off for indicating a 
weak coping capacity (116).
3.4.3 The Montreal Cognitive Assessment
The Montreal Cognitive Assessment (MoCA) was used to assess cognitive impair-
ment in patients with ALS (117). The MoCA consists of eight domains covering 
short time/work memory, visuospatial abilities, executive functions, attention, 
Table2. Overview of variables and self-reported standardized questionnaires in 
Studies I, II and III.
Variable Self-reported questionnaire Study
I II III
Disease severity ALS Functioning Rating Scale-Revised X X X
Coping capacity Sense of Coherence Scale X X
Cognitive impairment Montreal Cognitive Assessment X
Fatigue Checklist Individual Strength X X X
Anxiety Hospital Anxiety and Depression Scale X X X
Depression Hospital Anxiety and Depression Scale X X X
Pain Numeric Rating Scale X
Activities of daily living Katz Personal-ADL index X
Activities of daily living Katz Instrumental-ADL index X
Frequency of social and 
 lifestyle activities
Frenchay Activities Index X X X
Health-related quality of life Sickness Impact Profile X
Health-related quality of life EuroQol Visual Analogue Scale X X
Health-related quality of life Short-Form (36) Health Survey X
Life satisfaction Life Satisfaction Checklist-11 X
Experiences of caregiving Caregiver Reaction Assessment X
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concentration, language and orientation to time. A total score ranging from 0 to 
30 is calculated and lower scores indicate more severe cognitive impairment. The 
MoCA is considered valid (117, 118) and reliable (118).
In study II, a score of < 26 was used as cut-off for indicating cognitive impair-
ment (117).
3.4.4 The Checklist Individual Strength
The Checklist Individual Strength (CIS) was used to assess fatigue in patients with 
ALS (119). The CIS consists of 20 items, each graded from 1 to 7. A total score 
ranging from 20 to 140 is calculated, and a higher score indicates more severe dis-
ability. The scale comprises four subscale scores: subjective fatigue (score 8-56), 
concentration (score 5-35), motivation (score 4-28), and physical activity (score 
3-21). The CIS is considered valid (119, 120) and reliable (120).
In Studies I, II and III, a score of ≥ 35 on the subjective fatigue subscale was used 
as the cut-off for indicating fatigue (21, 121).
3.4.5 The Hospital Anxiety and Depression Scale
The Hospital Anxiety and Depression Scale (HADS) was used to assess anxiety 
and depression in patients with ALS (122). The scale comprises two sub-scales 
(anxiety and depression), both with seven items graded from 0 to 3. A total score 
ranging from 0 to 21 is calculated for each subscale, and a score of ≥ 8 indicates 
possible/probable anxiety and depression, respectively. A higher score indicates 
more severe disability. The HADS is considered valid (123) and reliable (123, 124).
In Studies I and III, a score of ≥ 8 in either of the two subscales was used as the 
cut-off for indicating possible/probable anxiety and/or depression. In Study II, 
scores ≥ 8 in the anxiety and depression subscales were used as the cut-offs for 
indicating anxiety and depression.
3.4.6 The Numeric Rating Scale of pain
A Numeric Rating Scale (NRS) ranging from 0 (no pain) to 10 (worst imaginable 
pain) was used to assess pain in patients with ALS. The question from the Brief 
Pain Inventory Short-Form (125) was used to identify patients perceiving pain: 
“Throughout our lives, most of us have had pain from time to time (such as minor 
headaches, sprains and toothaches). Have you had pain other than these every-
day kinds of pain the last week?” Patients answering yes were asked to rate their 
average pain experience using the NRS. Patients were asked to mark the number 
that best reflected their perceived pain. The NRS is considered valid (126, 127) 
and reliable (127). 
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In Study II, a score of ≥ 4 was used as the cut-off for indicating clinically relevant 
pain. The cut-off for this impairment was chosen in accordance with Karolinska 
University Hospital clinical guidelines, which state that pain scoring ≥ 4 on a 0-10 
NRS should be treated.
3.4.7 The Katz Personal-ADL index
The Katz Personal (P)-ADL index was used to assess P-ADL in patients with ALS 
(128). The index consists of the six items; feeding, bathing, dressing, continence, 
toileting and transfer, each scoring 0 if the patient is dependent and 1 if independent. 
A total score ranging from 0 to 6 is calculated. The Katz P-ADL index is consid-
ered valid and reliable (129).
In Study II, a score of ≤ 5 (less than the full sum score) was used as the cut-off for 
indicating dependency in P-ADL, which was considered to be an activity limitation.
3.4.8 The Katz Instrumental-ADL index
The Katz Instrumental (I)-ADL index was used to assess I-ADL in patients with ALS 
(128). The Katz I-ADL consists of the four items; cooking, cleaning, transporta-
tion and shopping, each scoring 0 if the patient is dependent and 1 if independent. 
A total score ranging from 0 to 4 is calculated. The Katz I-ADL index is considered 
valid and reliable (129).
In Study II, a score of ≤ 3 (less than the full sum score) was used as the cut-off for 
indicating dependency in I-ADL, which was considered to be an activity limitation.
3.4.9 The Frenchay Activities Index
The Frenchay Activities Index (FAI) was used to assess the frequency of social 
and lifestyle activities in patients with ALS (130). The FAI consists of 15 items 
graded from 0 (inactive) to 3 (highly active) relating to domestic chores, work/
leisure and outdoor activities. A total score ranging from 0 to 45 is calculated, and 
lower scores indicate more severe participation restrictions. The FAI is considered 
valid (131) and reliable (130, 132).
In Studies I, II and III, a score equal to or less than the 25th percentile of published 
sex- and age predictive normative values (131) was used as the cut-off for  indicating 
below norm frequency in social and lifestyle activities, which was considered to 
be a participation restriction.
3.4.10 The Sickness Impact Profile
The Sickness Impact Profile (SIP) was used to assess HRQL in patients with ALS 
(133). The SIP consists of 136 items covering 12 categories: sleep and rest,  emotional 
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behaviour, body care and movement, home management, mobility, social inter-
action, ambulation, alertness behaviour, communication, work, recreation and 
pastimes, and eating. Scores for all categories are calculated, as well as a total 
score (SIP overall) that consists of all 12 categories, a physical score (SIP physi-
cal) including 3 categories (ambulation, mobility, body care and movement) and 
a psychosocial score (SIP psychosocial), which includes 4 categories (social inter-
action, alertness behaviour, emotional behaviour, communication). Total scores 
from 0 to 100 are calculated, with higher scores indicating worse HRQL. The 
scores are expressed as percentage of impact of disease. The SIP is considered 
valid (134) and reliable (134).
3.4.11 The EuroQol Visual Analogue Scale
The EuroQol Visual Analogue Scale (EQ VAS) was used to assess HRQL in 
patients with ALS and in their next of kin (135). The EQ VAS consists of a vertical 
thermometer graded from 0 (worst imaginable health) to 100 (best imaginable 
health) on which the respondent marks their perceived overall health status today. 
The EQ VAS is considered valid (136) and reliable (136, 137).
3.4.12 The Short-Form (36) Health Survey
The Short-Form (36) Health Survey (SF-36) was used to assess HRQL in next of 
kin (87). The survey consists of 36 items, of which 1 question measures change in 
health status during the last year, while the other 35 items group into 8 subscales 
(physical functioning, role limitation, bodily pain, general health, vitality, social 
functioning, role limitation and emotional problems). An SF-36 Physical Component 
Summary (SF-36 physical) and an SF-36 Mental Component Summary (SF-36 
mental) index score can be calculated, both ranging from 0 to 100. Lower scores 
indicate worse HRQL. The SF-36 is considered valid and reliable (87).
3.4.13 The Life Satisfaction Checklist-11
The Life Satisfaction Checklist-11 (LiSat-11) was used to assess life satisfaction 
in next of kin (89). The LiSat-11 consists of 11 items, of which 1 item measures 
global satisfaction with life, ‘life as a whole’, and 10 items capture satisfaction 
with life in the following domains: vocation, economy, leisure, contacts, sexual 
life, family life, partner relationship, ADL, physical health and psychological 
health. Each item is graded from 1 (very dissatisfied) to 6 (very satisfied), and 
scores can be categorized into “satisfied” (≥ 5) or “not satisfied” (scores ≤ 4) (89).
In Study III, a score of ≥ 5 was used as the cut-off for indication of satisfaction 
with “life as a whole” (LiSat-11, item 1). 
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3.4.14 The Caregiver Reaction Assessment
The Caregiver Reaction Assessment (CRA) was used to assess experiences of care-
giving in next of kin (138). The scale captures both positive and negative experi-
ences of informal caregiving. The CRA consists of 24 items graded from 1 (does not 
apply at all) to 5 (applies completely) that can be grouped into five dimensions: 
self-esteem, family support, finances, schedule and health. Positive experiences 
are captured by the self-esteem dimension, whereas the other four dimensions 
describe negative experiences of caregiving. Dimension scores, ranging from 1 
to 5, are calculated, and higher scores indicate higher impact on the dimension. 
The CRA is considered valid (139) and reliable (139, 140).
In Study III, a score of ≥ 4 in the self-esteem dimension was considered to indicate 
a high positive impact in caregiving esteem. For the other four dimensions (family 
support, finances, schedule and health), a score of ≥ 3 was considered to indicate 
a high negative impact by describing lack of family support, financial problems, 
disrupted schedules and health problems. 
3.5 Data collection (Study IV)
Data on age, sex, relation to patient with ALS and work status in next of kin, as 
well as on time since diagnosis and duration of TIV in patients with ALS, were 
collected using standardized questions administered as an interview.
A semi-structured interview guide was developed in order to delve into the experi-
ence of being next of kin to someone with ALS who is undergoing TIV. The guide 
started with the question: “Can you tell us about an ordinary day in your everyday 
life?” This main question was followed by additional questions on, e.g., impact 
on daily life, involvement in care, expectations on social and health care person-
nel, thoughts about the situation with TIV, communication with the patient and, 
finally, advice to others including health care. All interviews were audio-taped 
and transcribed verbatim. 
3.6 Data analyses (Studies I, II and III)
An overview of the statistical methods used in Studies I, II and III is presented in 
Table 3. Descriptive statistics were used to present data, i.e., mean and standard 
deviation (SD), median and interquartile range (IQR), minimum and maximum 
values, frequency and percent. The Kolmogorov-Smirnov test, normality plots, 
and kurtosis and skewness values were used to check for normal distribution. The 
Mann-Whitney U and the Chi-squared tests were used to analyse differences in 
age and sex, respectively, between patients participating in Study I and those who 
declined/did not answer, and in Study II between patients still in the study after 
three years and those who dropped out of the study. 
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Table 3. An overview of statistical methods used in Studies I, II and III.
Statistical method Study I Study II Study III
Descriptive statistics X X X
Mann-Whitney U test X X
Chi-squared test X X X
Spearman rank correlation test X
Univariate linear regression analysis X
Multivariate linear regression analysis X X
Binary multivariate logistic regression analysis X
In Study I, stepwise multivariate linear regression analyses were used to explore 
associations between HRQL and the independent variables disease severity, fatigue, 
anxiety and/or depression, frequency of social and lifestyle activities, coping 
capacity and mechanical ventilator use, categorized according to the described 
cut-offs (Table 4).
In Study II, fatigue, anxiety, depression and clinically relevant pain were categorized 
according to the described cut-offs in section 3.4, and each patient’s total number 
of impairments was calculated. Descriptive statistics were used to explore rela-
tions between impairments and the three levels of disease severity (mild, moderate 
and severe). The Spearman rank correlation test was used to explore associations 
between disease severity and impairments. To facilitate interpretation, scores on 
fatigue, anxiety, depression and pain were inverted in these analyses so that higher 
scores reflected better functioning in all measures. The correlation coefficients 
were considered low if ≤ 0.49, moderate if 0.50 to 0.69, and high if ≥ 0.70 (141).
In Study III, stepwise multivariate linear regression analyses were used to explore 
associations between HRQL and independent variables i.e. caregiver experiences 
and factors related to informal caregivers and to the patient with ALS, categorized 
according to the described cut-offs (Table 4). The selection of independent vari-
ables to be used in the multivariate regression analyses was based on univariate 
analyses, i.e. a variable was selected if it was significantly associated with the 
dependent variable. A binary multivariate logistic regression analysis was used to 
explore the associations between satisfaction in “life as a whole” and the independ-
ent variables described above. 
Assumptions of regression models in Studies I and III were performed by analys-
ing outliers, independence and the normality distribution of residuals, and multi-
collinearity. The level of significance was set to p < 0.05, and analyses were 
performed with IBM SPSS Statistics 22 and 24 for windows.
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Table 4. Cut-offs for categorization of independent variables used in univariate and 
 multivariate regression analyses (Studies I and III).
Independent variable Cut-off Study
I III
Patient-related 
 Disease severity Severe (ALSFRS-R ≤29) X
 Disease severity Severe (ALSFRS-R ≤24) X
 Coping capacity Weak (SOC ≤54) X X
 Fatigue Fatigue (CIS fatigue subscale ≥35) X X
 Anxiety and/or depression Anxiety and/or depression (HADS ≥8) X X
 Social and lifestyle activities Below norm (FAI ≤25th percentile of norm values) X X
 Mechanical ventilation Yes X
 Homecare/personal assistance Yes X
Next of kin-related
 Age ≥65 years X
 Sex Man X
 Education level University X
 Cohabiting with patient No X
 Time spent on caregiving >7 h/week X
 Caregiving esteem High positive impact (CRA self-esteem ≥4) X
 Lack of family support High negative impact (CRA family support ≥3) X
 Financial problems High negative impact (CRA finances ≥3) X
 Disrupted schedule High negative impact (CRA schedule ≥3) X
 Health problems High negative impact (CRA health ≥3) X
ALSFRS-R: ALS Functioning Rating Scale-Revised, SOC: Sense of Coherence Scale, CIS: Checklist 
Individual Strength, HADS: Hospital Anxiety and Depression Scale, FAI: Frenchay Activities Index, 
CRA: Caregiver Reaction Assessment 
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3.7 Data analysis (Study IV)
Qualitative content analysis with an inductive approach (142, 143) was used for 
analysis of interviews on the experiences of next of kin to patients with ALS 
undergoing TIV. The units of analysis were the recorded interviews, which were 
transcribed verbatim. The steps of the analysis are described below:
1. The transcribed interviews were read through several times to get a sense 
of their content.
2. The text was divided into meaning units comprising words, sentences or 
paragraphs related to each other by their content and context.
3. The meaning units were condensed, i.e. the text was shortened without 
interpretation and still contained the core of the meaning units.
4. Each condensed meaning unit was, in a process to interpret the underlying 
meaning, labelled with a code.
5. Codes were compared, and those with similar content were grouped into 
subthemes. The initial number of subthemes was reduced after a process 
of re-reading codes and reconsidering the interpretation of the underlying 
meaning and the whole context, and thus, moving between the whole and 
parts of the text.
6. The subthemes were analysed by their latent content in a process to answer 
how next of kin experienced TIV for their relative with ALS. Three main 
themes were constructed based on the underlying meaning of the subthemes.
3.8 Ethical considerations
Ethical approvals were obtained from the ethical review board in Stockholm, 
Sweden, registration number 2012/842-31/2 (Studies I, II and III) and registration 
number 2016/1086-31 (Study IV). All procedures were conducted in accordance 
with the Helsinki Declaration, and all participants received oral and written infor-
mation and had to give their consent before inclusion. 
Studies in patients with the progressive fatal disease ALS and their next of kin 
require serious ethical considerations, as both patients and next of kin might be 
psychologically and emotionally vulnerable. It is important to respect individuals’ 
situations and not to induce any additional strain. In the present studies, care was 
taken to assert that the time and day for the data collections were according to the 
participants’ wishes and that procedures were not too tiring. The data collectors 
had clinical experience in ALS but were not involved in actual care of participants. 
If needed, data collectors informed participants about where to go for professional 
support in different matters.
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4 RESULTS
4.1 Patient inclusion and retention, patient characteris-
tics and contextual factors (Studies I and II)
The inclusion and retention of patients with ALS during the three-year study period 
is presented in Figure 2. Twelve of the sixty patients included at baseline (T1) 
were still in the study at the last data collection. The median time since diagnosis 
at baseline was longer for those 12 (41 months) compared to the other 48 patients 
(16 months). Altogether, 23 patients declined participation at some time point 
after baseline, with the most common reasons being that the participants were too 
fatigued or in a terminal stage of ALS.
Information on patient characteristics and contextual factors at each data collection 
during the three-year study period is presented in Table 5. At baseline, the median 
age was 61 years, and the proportion of men and women was almost equal, with 
53% of patients being men. The spinal form of ALS was more common than the 
bulbar, ranging from 75% of the patients at baseline to 92% at the last data collec-
tion (not shown in Table 5). All but three patients with ALS lived in their own 
home during the study period. Depending on data collection time point, disease 
modifying medication was prescribed to 76-86% and anti-depressives to 18-48%. 
Furthermore, having aids, home adaptations and services such as home care, per-
sonal assistance and transport service were reported by 52-100% of the patients. At 
baseline, 7 (14%) of 52 patients who answered the questionnaire on coping capacity 
(SOC) were classified as having weak coping capacity (not shown in Table 5).
4.2 Disease severity and disability in patients with ALS 
(Studies I and II)
Disease severity and disability at each data collection during the three-year study 
period is presented in Table 6. As expected, disease severity (ALSFRS-R) pro-
gressed over time, and no one was categorized as having mild disease after two 
years. Depending on data collection time point, fatigue was found in 31-61% of 
the patients, anxiety in 0-25%, depression in 11-36% and clinically relevant pain 
in 24-38%. Anti-depressive medication was prescribed for patients scoring above 
and under the cut-off for depression (not shown in tables). No results on cognitive 
impairment are presented, as 60-80% of the patients were unable to complete all 
parts of the used measure (MoCA) due to physical disability. Activity limitations 
and participation restrictions were common, and most patients were already at 
baseline dependent in ADL and reported severely reduced frequency (below norm) 
in social and lifestyle activities. 
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Table 5. Information on patient characteristics and contextual factors at each data collection (T1-T7) during the three-year study 
period. N represents the number of patients participating at each time point.
T1 (N=60) T2 (N=38) T3 (N=29) T4 (N=17) T5 (N=14) T6 (N=14) T7 (N=12)
Age, years, median (IQR) 61 (55-69) 60 (54-67) 61 (53-66) 61 (48-68) 63 (58-68) 62 (50-67) 63 (48-68)
Men, n (%) 32 (53) 21 (55) 17 (59) 11 (65) 10 (71) 8 (57) 6 (50)
Time since diagnosis, months, 
median (IQR)
17 (8–35) 24 (14–57) 35 (20–82) 52 (32–107) 60 (36–123) 65 (45–129) 77 (50–152)
Own accommodation, n (%) 58 (97) 36 (95) 28 (97) 16 (94) 14 (100) 14 (100) 12 (100)
Living with family member, n (%) 45 (75) 31 (82) 23 (79) 14 (82) 12 (86) 12 (86) 10 (83)
Medications
 Disease modifying, n (%) 46 (77) 29 (76) 23 (79) 13 (77) 12 (86) 12 (86) 10 (83)
 Symptomatic, n (%) 27 (45) 22 (58) 15 (52) 10 (59) 7 (50) 8 (57) 10 (83)
 Anti-depressive, n (%) 16 (27) 11 (29) 14 (48) 3 (18) 5 (36) 3 (21) 4 (33)
Ventilation
 Non-invasive, n (%) 18 (30) 11 (29) 5 (17) 3 (18) 3 (21) 3 (21) 3 (25)
 Invasive, n (%) 4 (7) 3 (8) 3 (10) 3 (18) 3 (21) 5 (36) 4 (33)
Gastrostomy, n (%) 18 (30) 11 (29) 11 (38) 5 (29) 6 (43) 7 (50) 7 (58)
Aids
 Mobility, n (%) 49 (82) 35 (92) 28 (97) 16 (94) 13 (93) 14 (100) 12 (100)
 Activities of daily living, n (%) 43 (72) 31 (82) 24 (83) 15 (88) 12 (86) 13 (93) 12 (100)
 Communication, n (%) 36 (60) 23 (61) 17 (59) 11 (65) 11 (79) 13 (93) 11 (92)
Home adaptations, n (%) 34 (57) 27 (71) 23 (79) 13 (77) 12 (86) 13 (93) 12 (100)
Home care, n (%) 15 (25) 9 (24) 7 (24) 2 (12) 2 (14) 2 (14) 3 (25)
Personal assistance, n (%) 16 (27) 15 (39) 16 (55) 10 (59) 8 (57) 9 (64) 7 (58)
Transport service, n (%) 40 (67) 32 (84) 27 (93) 17 (100) 14 (100) 14 (100) 12 (100)
IQR: interquartile range.
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Table 6. Disease severity and disability in patients with ALS at each data collection (T1-T7) 
during the three-year study period. N represents the number of patients  participating at each 
time point and n indicates the number of patients having answered the questionnaires.
T1 
(N=60)
T2 
(N=38)
T3 
(N=29)
T4 
(N=17)
T5 
(N=14)
T6 
(N=14)
T7 
(N=12)
n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Disease severity 
 Mild 20 (33) 6 (16) 5 (17) 1 (6) 1 (7) - -
 Moderate 17 (28) 19 (50) 10 (35) 9 (53) 4 (29) 6 (43) 4 (33)
 Severe 23 (39) 13 (34) 14 (48) 7 (41) 9 (64) 8 (57) 8 (67)
Fatigue
 Yes 31 (61) 21 (58) 13 (50) 7 (41) 6 (43) 4 (31) 6 (50)
 No 20 (39) 15 (42) 13 (50) 10 (59) 8 (57) 9 (69) 6 (50)
Anxiety
 Yes 14 (25) 9 (25) 3 (11) 2 (12) 2 (14) 0 (0) 2 (17)
 No 42 (75) 27 (75) 24 (89) 15 (88) 12 (86) 14 (100) 10 (83)
Depression
 Yes 12 (21) 10 (28) 3 (11) 4 (31) 5 (36) 3 (21) 2 (17)
 No 44 (79) 26 (72) 24 (89) 13 (69) 9 (64) 11 (79) 10 (83)
Pain
 Yes, clinically relevant 14 (24) 12 (32) 11 (38) 6 (35) 3 (21) 5 (36) 3 (25)
 Yes, below cut-off 7 (12) 4 (10) 3 (10) 2 (12) 0 (0) 1 (7) 3 (25)
 No 38 (64) 22 (58) 15 (52) 9 (53) 11 (79) 8 (57) 6 (50)
Personal ADL
 Dependent 41 (68) 29 (76) 25 (86) 16 (94) 12 (86) 14 (100) 12 (100)
 Independent 19 (32) 9 (24) 4 (14) 1 (6) 2 (14) 0 (0) 0 (0)
Instrumental ADL
 Dependent 52 (87) 37 (97) 28 (97) 16 (94) 14 (100) 14 (100) 12 (100)
 Independent 8 (13) 1 (3) 1 (3) 1 (6) 0 (0) 0 (0) 0 (0)
Social and lifestyle 
activities
 Below norm 47 (78) 35 (92) 27 (93) 16 (94) 14 (100) 14 (100) 12 (100)
 Within norm 13 (22) 3 (8) 2 (7) 1 (6) 0 (0) 0 (0) 0 (0)
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The number of patients having fatigue, anxiety, depression and clinically relevant 
pain in relation to disease severity level at each data collection during the three-year 
study period is presented in Figure 3. Presence of these impairments was found in 
all disease severity levels, i.e. in those categorized as having mild, moderate and 
severe disease. Concurrent presence of fatigue, anxiety, depression and clinically 
relevant pain at each data collection is presented in Figure 4. Depending on data 
collection time point, between 23% and 42% of the patients had two or more of 
these impairments concurrently. The impairments (fatigue, anxiety, depression 
and clinically relevant pain) were not considered to be related to disease severity 
as correlation coefficients were low.
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Figure 3. Presence of fatigue, anxiety, depression and clinically relevant pain in 
 relation to disease severity (mild, moderate and severe) at each data collection (T1-T7) 
during the three-year study period.
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Figure 4. Concurrent presence of the impairments fatigue, anxiety, depression and 
 clinically relevant pain at each data collection (T1-T7) during the three-year study period.
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4.3 Predictors of HRQL in patients with ALS (Study I)
Results of HRQL measures at baseline in patients with ALS are presented in Figure 5. 
The physical dimension of HRQL (SIP physical) was more severely affected than 
the psychosocial dimension (SIP psychosocial). The variation in patients’ ratings 
of their perceived overall health status today (EQ VAS) was wide, with a median 
value of 50, i.e. precisely between worst and best imaginable health.
The results from the multivariate regression analyses of predictors of HRQL in 
patients with ALS are presented in Table 7. Participation restriction, i.e. below the 
norm frequency in social and lifestyle activities, severe disease and weak coping 
capacity predicted worse overall HRQL (SIP overall). Participation restriction in 
social and lifestyle activities and severe disease predicted worse physical HRQL 
(SIP physical), and severe disease, weak coping capacity and presence of anxiety 
and/or depression were predictors of worse psychosocial HRQL (SIP psycho social). 
Fatigue and use of mechanical ventilator were predictors of worse overall health 
status (EQ VAS).
Figure 5. Box plots of health-related quality (HRQL) measures at baseline in patients 
with ALS. Higher scores in Sickness Impact Profile (SIP) overall, SIP physical and SIP 
psychosocial indicate worse HRQL, and lower scores in EuroQol Visual Analogue Scale 
(EQ VAS) indicate worse HRQL.
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Table 7. Results of multivariate regression analyses on predictors of health-related quality of life in patients with ALS.
Dependent variable Independent variable Unstandardized coefficients P-value Adjusted R²
Total variance 
explained
B 95% CI
SIP overall (n=51) Participation restriction (FAI ≤25th percentile 
of norm values)
10.3 5.4 to 15.3 <0.001 0.42 42%
Severe disease (ALSFRS-R ≤29) 9.1 5.0 to 13.2 <0.001 0.12 54%
Weak coping capacity (SOC ≤54) 6.2 0.8 to 11.5 0.025 0.04 58%
SIP physical (n=51) Participation restriction (FAI ≤25th percentile 
of norm values)
17.5 10.2 to 24.9 <0.001 0.44 44%
Severe disease (ALSFRS-R ≤29) 11.6 5.6 to17.7 <0.001 0.13 57%
SIP psychosocial (n=51) Severe disease (ALSFRS-R ≤29) 7.3 2.4 to 12.1 0.004 0.17 17%
Weak coping capacity (SOC ≤54) 8.4 1.3 to 15.4 0.021 0.11 28%
Anxiety and/or depression (HADS ≥8) 5.2 0.1 to 10.3 0.045 0.05 33%
EQ VAS (n=50) Fatigue (CIS fatigue subscale ≥35) -18.4 -32.2 to -4.6 0.010 0.10 10%
Mechanical ventilator (yes) -17.0 -32.1 to -2.0 0.027 0.07 17%
CI: Confidence interval, SIP: Sickness Impact Profile, EQ VAS: EuroQol Visual Analogue Scale, FAI: Frenchay Activities Index, ALSFRS-R: ALS 
Functional Rating Scale Revised, SOC: Sense of Coherence Scale, HADS: Hospital Anxiety and Depression Scale, CIS fatigue: Checklist Individual 
Strength fatigue subscale.
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4.4 Informal caregiver characteristics (Study III)
All next of kin in Study III performed unpaid caregiving and were therefore consid-
ered to be informal caregivers. (See Table 8 for information on informal caregiver 
charac teristics.) Most informal caregivers were women (69%), and 67% of all informal 
caregivers cohabitated with the patient with ALS. The reported median (IQR) time 
spent on informal caregiving was 18 (6-50) hours per/week (not shown in Table 8).
Table 8. Information on informal caregiver characteristics.
Informal caregivers
Age, years, median (IQR) 60 (49-67)
Women, n (%) 34 (69)
Work status, full/part time, n (%) 14/16 (29/33)
Changed working time (after ALS diagnosis), n (%) 15 (31)
Relation to patient with ALS, n (%)
 Partner/ex-partner 31/2 (63/4)
 Child 8 (26)
 Parent/sibling/friend 1/6/1 (2/12/2)
Cohabiting with patient with ALS, n (%) 33 (67)
Informal caregiving >7 hours/week, n (%) 35 (71)
IQR: interquartile range
4.5 Caregiver experience, HRQL and life satisfaction in 
informal caregivers (Study III)
Results on positive and negative caregiver experiences (CRA) are presented in Figure 6. 
High positive impact on self-esteem was reported by 30 (63%) informal caregivers. 
High negative impact was reported by 30 (63%) in schedule and by 20 (42%) in 
health, i.e. many informal caregivers had disrupted schedules and health problems. 
Results of HRQL measures in informal caregivers to patients with ALS are presented 
in Figure 7. The mental dimension of HRQL (SF-36 mental) was more severely 
affected than the physical dimension (SF-36 physical). The variation in informal 
caregivers’ ratings of their perceived overall health status today (EQ VAS) was 
wide with a median value of 75.
Results of life satisfaction in informal caregivers to patients with ALS are presented 
in Figure 8. Fourteen (30%) informal caregivers were satisfied with “life as a whole” 
(LiSat-11, item 1), and 11 (23%) and 7 (15%) reported being satisfied in the leisure 
and sexual life domains, respectively.
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Figure 6. Results on positive (self-esteem) and negative (health, schedule, finances 
and family support) caregiver experiences in informal caregivers to patients with ALS. 
Numbers of patients reporting high and low impact in the five dimensions of the 
Caregiver Reaction Assessment questionnaire.
Figure 7. Box plots on health-related quality of life (HRQL) measures in informal 
 caregivers to patients with ALS. Lower scores in SF-36 Physical Component Summary 
(SF-36 physical), SF-36 Mental Component Summary (SF-36 mental), and EuroQol 
Visual Analogue Scale (EQ VAS) indicate worse HRQL.
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4.6 Factors associated with HRQL and life satisfaction 
in informal caregivers (Study III)
Results of multivariate regression analyses on factors associated with informal care-
givers’ HRQL are presented in Table 9. Anxiety and/or depression in patients with 
ALS was associated with worse physical HRQL (SF-36 physical), while the disrupted 
schedules of informal caregivers were associated with better physical HRQL. Older 
age and high self-esteem in informal caregivers were associated with better mental 
HRQL (SF-36 mental), while informal caregivers’ disrupted schedules and health 
problems were associated with worse mental HRQL. Male sex and health problems 
in informal caregivers were associated with worse overall health status (EQ VAS).
The binary multivariate logistic regression analysis showed that older age in infor-
mal caregivers and not cohabiting with patients with ALS were associated with 
being satisfied with “life as a whole” (LiSat-11, item 1). The odds ratio (95% CI) 
for older age was 11 (2-61), p=0.006 and for not cohabiting 7 (1-41), p=0.028.
Figure 8. Results on life satisfaction in informal caregivers to patients with ALS. Numbers 
of patients reporting being satisfied and not satisfied in the 11 domains of the Life 
Satisfaction Checklist-11 questionnaire.
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Table 9. Results of multivariate regression analyses on factors associated with health-related quality of life in informal caregivers to 
patients with ALS. 
Dependent variable Independent variable Unstandardized coefficients P-value Adjusted R²
Total variance 
explained
B 95% CI
SF-36 physical (n=45) Anxiety and/or depression in patient (HADS ≥8) -9.3 -16.4 to -2.2 0.011 0.12 12%
Disrupted schedule (CRA schedule ≥3) 7.8 0.8 to 14.7 0.028 0.07 19%
SF-36 mental (n=46) Age (≥65 years) 15.1 8.4 to 21.8 <0.001 0.27 27%
Health problems (CRA health ≥3) -8.7 -15.7 to -1.7 0.016 0.18 45%
Disrupted schedule (CRA schedule ≥3) -9.4 -16.5 to -2.3 0.011 0.05 50%
Caregiving esteem (CRA self-esteem ≥4) 7.2 0.6 to 13.8 0.033 0.04 54%
EQ VAS (n=47) Sex (man) -19.7 -31.8 to -7.5 0.002 0.15 15%
Health problems (CRA health ≥3) -21.1 -32.6 to -9.7 0.001 0.13 28%
CI: confidence interval, SF-36 physical: SF-36 Physical Component Summary, SF-36 mental: SF-36 Mental Component Summary, EQ VAS: EuroQol 
Visual Analogue Scale, HADS: Hospital Anxiety and Depression Scale, CRA: Caregiver Reaction Assessment.
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4.7 Experiences of next of kin to patients with ALS 
undergoing TIV (Study IV)
Characteristics of next of kin and patients are presented in Table 10. Three main 
themes and nine subthemes emerged from the qualitative content analysis (Table 11). 
The first theme, “A turbulent care process aiming to extend life”, described the 
perceived chaotic situation that emerged when a tracheostomy had been carried 
out in an emergency situation. Although TIV had been discussed and sometimes 
planned, next of kin felt they lacked knowledge and were uncertain of the reasons 
underlying the patient’s choice of invasive ventilation. However, TIV meant that the 
focus changed from thoughts of the patient’s immediate death to prolonging life. 
The period after the emergency surgery was described as turbulent with  inadequate 
support and information, and that the care was of a low standard until the patient 
was transferred to the Respiratory Centre. The period of hospitalization after TIV 
was initiated was perceived as surprisingly long.
Table 10. Characteristics of next of kin (n=8) and patients with ALS requiring invasive 
ventilation via tracheostomy (n=6).
Study IV
Next of kin
 Age, years, median (min-max) 49 (27-64)
 Women/men, n 6/2
 Relation
  Wife, n 3
  Parent, n 2
  Children 3
 Cohabiting with patient, n 4
 Work status
  Full time/part time as personal assistant, n 3/4
Patients with ALS
 Time since diagnosis, years, median (min-max) 4 (3-12)
 Invasive ventilation, years, median (min-max) 2 (1-7)
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The second theme, “Struggling to cope with the strains of everyday life”, described 
the experiences of having to adapt to the situation of home care of a patient with 
TIV. Next of kin put their own lives on hold and adapted to the needs of the patient. 
Some perceived TIV as terrifying, as the patient would die without it, while  others 
described it as one of several aids that made life easier. Home care brought about 
a change to a more hospital-like home with a constant presence of employed 
formal caregivers. A well-functioning situation regarding these caregivers was, 
however, a prerequisite for next of kin to be able to feel secure. In everyday life, 
the patient’s loss of ability to communicate was perceived as a major difficulty 
and involved uncertainties in the understanding of the patient and a feeling that 
the patient had changed as a person.
The third theme, “Conflicting roles as next of kin and carer”, described how next 
of kin felt that they had become the patient’s unofficial guardian. This task was 
accompanied by a heavy work load, and they lacked help in co-ordinating the 
care of the patient. Difficulties in maintaining their relationship as a close relative 
while also working as a formal caregiver were described. They expressed a need 
for psychological and social support as next of kin and as carers and in issues 
related to ALS and TIV.
Table 11. The results of the qualitative content analysis of experiences in next of kin 
to patients with ALS undergoing invasive ventilation via tracheostomy.
Theme Subtheme
A turbulent care process aiming to extend life Feeling insecure in a tense 
 emergency situation
A roller-coaster care process
Struggling to cope with the strains of everyday life Putting one’s own life on hold
The challenge of coping with 
 life-giving TIV
Reliance on personal assistance 
needed to feel secure
The struggle to communicate when 
the power of speech is lost
Conflicting roles as next of kin and carer Being an unofficial guardian
Contradictory relationship roles 
A desire for support and guidance in 
the carer role
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5 DISCUSSION
This thesis aimed to explore aspects of disability, contextual factors and HRQL 
in patients with ALS, and to explore informal caregivers’ HRQL and life satisfac-
tion. Further, to investigate the experiences of being next of kin to patients with 
ALS undergoing TIV.
5.1 Main findings
Regardless of disease severity, patients with ALS were found to experience fatigue, 
anxiety, depression and pain concurrently. The health condition, i.e. high disease 
severity; the impairments fatigue, anxiety and/or depression; participation restric-
tions, i.e. low frequency of social and lifestyle activities; and the contextual factors 
weak coping capacity and mechanical ventilator use (non-invasive and TIV) were 
associated with worse HRQL in patients with ALS. Anxiety and/or depression in 
patients with ALS, and informal caregivers’ negative caregiving experiences and 
male sex were associated with worse HRQL in informal caregivers, while posi-
tive caregiving experiences and older age were associated with better HRQL. As 
for life satisfaction, older age and not cohabiting with the patient were  associated 
with being satisfied with “life as a whole”. The following main themes were 
identified in the qualitative analyses of the experiences of being next of kin to 
patients with ALS undergoing TIV: “A turbulent care process aiming to extend 
life”; “Struggling to cope with the strains of everyday life”; and “Conflicting roles 
as next of kin and carer”.
5.2 Disability in patients with ALS (Studies I and II)
Although patients with ALS present many various impairments, the focus in this 
thesis were on such impairments that are amenable to health care interventions. 
Fatigue was the most common impairment at all data collection time points. Fatigue 
can be said to consist of a physiological (central and peripheral fatigue) and a 
psychological dimension (depression, concentration and motivational influences) 
(144). Both dimensions are thought to influence patients’ perceptions of fatigue 
as adaptation mechanisms in the central nervous system early in the development 
of the disease, and there is obvious psychological stress related to having ALS. 
Although fatigue was common among the patients studied here, it did not seem 
to increase over time. It can be speculated that patients became less physically 
active due to progressive muscle weakness and, thus, were less fatigued. Such 
explanation would be in accordance with a previous report that patients with ALS 
describe fatigue as a use-dependent reversible muscle weakness and a whole-body 
tiredness (145). Both pharmacological and non-pharmacological interventions for 
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fatigue have been studied, but it is not possible to draw any conclusion on their 
effectiveness, as the quality of the available evidence is low (146). It was recently 
reported that fatigue is the most prevalent symptom in patients with ALS, and at 
the same time it is the least treated (147). Thus, there is a great need for scientific 
studies regarding interventions to reduce fatigue.
The number of patients with anxiety and depression seemed to decrease over time. 
Perhaps this was due to the shorter time from diagnosis in patients at baseline. i.e. 
the perceived psychological strain might decrease over time due to acceptance 
and other coping strategies. Regardless of data collection time point, there were 
patients with anxiety and/or depression who lacked anti-depressive medication, 
indicating possible under-treatment. In addition to medication, non-pharmacological 
interventions should be considered, e.g. cognitive behavioural therapy which has 
shown the potential to decrease anxiety and depression in patients with ALS (148).
Pain has been highlighted as a largely neglected impairment in patients with ALS 
(149). The findings that, regardless of data collection time point, approximately 
half of the patients experienced pain, and that most were categorized as having 
clinically relevant pain and thereby were considered as undertreated, provide new 
and important knowledge. There are many underlying causes for that pain that 
patients with ALS experience, e.g. there may be pain due to muscle weakness, 
cramps, spasticity, contractures and immobilization, which is why proper pharmaco-
logical and non-pharmacological interventions to reduce pain are needed (149). 
Activity limitations in P- and I-ADL and participation restrictions were present in 
patients with ALS at all data collection time points and increased over time. This 
was found despite that, on a group level, patients apparently had access to aids, 
support and services. It would therefore be interesting to explore the timing, use 
and satisfaction of the prescribed aids, as well as the granted support and services 
from an individual perspective, to get a better understanding of how to reduce 
activity limitations and participation restrictions. Although multidisciplinary care, 
including physio- and occupational therapy-related interventions, are thought to 
be beneficial, the knowledge of the impact of such interventions to decrease par-
ticipation restrictions in patients with ALS is limited and, thus, needed (150, 151). 
The findings that patients with ALS, regardless of disease severity, experienced 
fatigue, anxiety, depression and pain over time, with approximately one-third 
 having two or more impairments at the same time, and further, that activity limi-
tations and participation restrictions were common, indicate the need for regular 
screening so that person-centred care can be applied at the right time.
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5.3 Predictors of HRQL in patients with ALS (Study I)
That disease severity was associated with both physical and psychosocial dimen-
sions of HRQL, i.e. severe disease with worse HRQL, corroborates what has previ-
ously been reported (91, 95, 101). The results indicate that is valuable to monitor 
disease severity in patients as it influences their HRQL, and furthermore, that 
patients might need enhanced care and support during severe stages of the disease.
In line with the results presented in this thesis, the relationship between fatigue 
and HRQL in patients with ALS seems to be inconclusive, as both an association 
with worse HRQL and a lack of association have been reported (93, 99, 152). The 
use of different measures, both for fatigue and HRQL, is a possible explanation 
for the discrepancies found in these associations. However, as HRQL is a multi-
dimensional construct, it can be necessary to have complementary measures when 
exploring the impact of fatigue on HRQL.
Anxiety and/or depression were found to be associated with worse HRQL, a find-
ing in line with previous reports (93, 94, 153). It is important to screen for these 
impairments, as in addition to having a negative impact on HRQL, it was found 
that anxiety and depression might be under-treated in patients with ALS.
Participation restrictions, i.e. low frequency of social and lifestyle activities, were 
associated with worse overall and physical HRQL, which underlines the impor-
tance of intervention and support for facilitating activities in domestic life and 
social participation.
The finding of an association between weak coping capacity and worse HRQL 
indicates that coping capacity, as captured by SOC, is an important factor to con-
sider in the ALS population. The result is also in line with findings in patients 
with other various diseases where a stronger sense of coherence is found to be 
associated with better HRQL (154). It has been debated whether a person’s sense 
of  coherence is a stable entity, formed in young adulthood and stabilized around the 
age of 30, as proposed by Antonovsky (155), or if it is subject to change. The latter 
is supported by the evidence found of increasing SOC scores as one ages across 
the entire life span (114). Thus, it may be possible to change a person’s sense of 
coherence/coping capacity. Suggested crucial components for interventions aiming 
to strengthen coping capacity are empowerment and reflection processes (156).
Mechanical ventilator use was found to be associated with worse HRQL. Although 
a bit surprising, the finding might be related to the fact that mechanical ventilation 
included both non-invasive ventilation and TIV. It has previously been reported 
that non-invasive ventilation is associated with better HRQL (100, 101), while 
invasive ventilation might worsen patients’ HRQL (102). That most patients with 
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ALS in need of mechanical ventilation have a high degree of disease severity 
and that disease severity has an impact on HRQL (91, 95, 101) might be another 
possible explanation of the result.
5.4 Caregiver experience, HRQL and life satisfaction in 
informal caregivers (Study III)
That informal caregivers spent a substantial amount of time on caregiving are in 
line with previous findings on caregiving in both patients with ALS (71, 74, 157, 
158) and other neurological diseases (159-161). The Swedish disability policy 
includes the right for people with disabilities to apply for social services such as 
personal assistance and home care, and many of the patients in this study made 
use of these services. Despite this, informal caregivers provided care for several 
hours almost every day. However, it is likely that these caregiving efforts made it 
possible for patients to live in their homes.
Caregiving experience is a multi-faceted construct with both positive and negative 
sides (76). Most studies on caregiving for patients with ALS explore negative 
aspects (74, 162, 163), and only a few studies report on positive caregiving expe-
riences (77, 78). That approximately two-thirds of the informal caregivers had a 
high positive impact in the self-esteem dimension is therefore an important finding. 
In line with previous studies, where high time-consuming burden (164, 165) and 
time restrictions (74, 166) are reported as negative caregiver experiences, a high 
negative impact was found in the schedule dimension. These findings on caregiver 
experiences provide knowledge that can be used in health care. For example, infor-
mal caregivers with positive experiences in caregiving could be valuable as role 
models or facilitators in support groups for informal caregivers to patients with 
ALS. Further, it is possible that the enhanced involvement of informal  caregivers 
in the care-planning of the patient with ALS might reduce negative caregiver 
experience. Whether the involvement of informal caregivers in care planning has 
this effect, however, needs to be further studied.
Negative caregiver experiences are reported to be associated with worse HRQL 
in caregivers to ALS patients (74). That disrupted schedule was associated with 
better physical HRQL was therefore a bit surprising. A possible explanation 
might be that informal caregivers with better physical HRQL are more active and 
therefore perceive a high negative impact on their schedule dimension, as care-
giving interrupts other activities. Interestingly, a positive caregiver experience 
was associated with better mental HRQL, which underscores the importance of 
exploring both positive and negative sides of caregiving. Older age in informal 
caregivers was associated with better mental HRQL, a result in line with a previ-
ous study (104). That male sex in informal caregivers was associated with worse 
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HRQL contradicted a previous study where females rated their HRQL worse than 
males (167). Female informal caregivers are also reported to experience higher 
caregiver burden than men (165). These findings highlight the need for studies on 
gender differences in this area. Anxiety and/or depression in patients were associ-
ated with worse physical HRQL in informal caregivers. There was, however, no 
association between patients’ disease severity and HRQL in informal caregivers, 
which corroborates what others report (29, 167-169). Thus, one can assume that 
patients’ mental issues have a greater impact on informal caregivers’ HRQL than 
patients’ disease severity.
Life satisfaction in informal caregivers to patients with ALS was low compared 
to both informal caregivers to stroke patients (108, 109) and to Swedish refer-
ence levels (89). Although approximately one-third were satisfied with “life as a 
whole”, few informal caregivers were satisfied in the domains concerning leisure 
and sexual life. Sexual interest, activity and satisfaction have been reported to 
decrease in patients with ALS and in their partners compared to the time before 
disease onset; however, the issue of sexuality is seldom addressed by health care 
professionals in general (170). Given the importance of sexuality, this is an area 
where health care needs to develop both strategies and interventions to support 
patients and their caregivers/partners.
It has been reported that younger age is associated with being satisfied with life 
(94), a finding in contrast to the result in this study that older age ( ≥ 65 years) is 
associated with being satisfied with “life as a whole”. Although not studied, older 
informal caregivers might be more satisfied because they do not need to combine 
informal caregiving with work demands. Furthermore, the aspirations for a healthy 
life and the expectations of life satisfaction possibly change with age. Not cohabiting 
with the patient was another factor associated with being satisfied with “life as a 
whole”. Such an association might be because cohabiting with the patient possibly 
increases the strain in the lives of informal caregivers and reduces the time they 
can devote to their own activities.
5.5 Experiences of next of kin to patients with ALS 
undergoing TIV (Study IV)
Next of kin described the implementation of TIV as a turbulent care process that 
leads to continued life for their family member. Even though TIV had been dis-
cussed, tracheostomy was mostly performed in an acute setting. That patients with 
ALS undergo tracheostomy in emergencies is not unusual: it is reported to be the 
case in 44-67% of those undergoing TIV (59, 62, 171). This indicates a need for 
improving the protocol for implementing TIV in a safe and timely fashion, e.g. by 
establishing a care plan for management before respiratory complications occur, 
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a plan that both next of kin and patient feel comfortable with. That the hospitali-
zation period after undergoing a tracheostomy was described as being turbulent 
and surprisingly long, implies that next of kin were not prepared for all the matters 
to be sorted out before the patient could return home. Though not available for 
patients and next of kin at the time of the tracheostomy in this study, there are 
now local guidelines (172) on how to implement TIV and how follow-up care 
after discharge from the Respiratory Centre. The extent to which next of kin are 
actively involved is, however, unknown.
It is known that the burden of care for caregivers to patients with ALS is sub-
stantial. Furthermore, it is known that next of kin providing care to TIV patients, 
ALS and other diagnoses perceive high levels of physical and emotional burden, 
and worse QoL than others (83, 173-176). Next of kin participating in Study IV 
described struggling to cope with the strains of everyday life, of placing all their 
focus on their patients, and of feeling that their own lives had been put on hold. 
That next of kin centre on the situations of their patients and set aside their own 
needs are consistent with the findings of other studies (166, 177, 178). The need 
for support for next of kin to patients with ALS has previously been highlighted 
(71, 166, 173, 179), but there is less literature describing how this support can be 
organized and delivered. Next of kin in Study IV described the dramatic shift in 
the situation at home that home care for a patient undergoing TIV brought about. 
If individually adapted information about the inevitable changes in the home situ-
ation were supplied, with regular follow-ups giving opportunity for reflection, 
next of kin might be better prepared and able to cope with the new situation better.
Next of kin described experiencing conflicting roles as next of kin and carer. That 
most were employed as formal caregivers, i.e. personal assistants, indicates that the 
lines between formal and informal care might be blurred, as well as those between 
work and free time. They also expressed a need for psychological and social sup-
port for them as next of kin and carers and in issues related to ALS and TIV. As 
for issues related to TIV, it is reported that a hands-on education programme for 
patients and their next of kin, in addition to providing the best available informa-
tion, also assists in decision-making with respect to ventilatory support (180).
5.6 Methodological considerations
Patients with ALS participating in Studies I and II were recruited from the ALS 
clinic at the Karolinska University Hospital. This clinic serves all patients with ALS 
living in Stockholm County, a county with approximately two million inhabitants, 
i.e. one-fifth of Sweden’s population. All patients had been diagnosed as having 
ALS according to the El Escorial criteria, i.e. there were signs of both upper and 
lower motor neuron involvement. Although 22 of 82 eligible patients declined to 
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participate in the study, the patient characteristics, including age, sex and onset 
form, of the 60 included at baseline were in agreement with reports from European 
population-based studies (6, 181, 182). Furthermore, no significant differences 
concerning age and sex were found between the 22 who declined and the 60 
patients participating. 
Participants in Study III were identified by patients with ALS (Study I) as being 
next of kin to them. Forty-nine of 58 identified as next of kin agreed to participate, 
and they were regarded as informal caregivers, as all provided unpaid care for 
patients with ALS. The relationship to the patient with ALS differed among the 
informal caregivers, and there was a variety in age and sex. Thus, it can be argued 
that the study samples were representative of patients with ALS and their informal 
caregivers, which strengthens the external validity of the study.
Next of kin participating in Study IV were recruited via patients with ALS under-
going TIV. As treatment with TIV is uncommon, it is not surprising that the study 
sample was small. There were, however, differences in age, sex, and the relation-
ship to the patient undergoing TIV among the six next of kin, meaning that exist-
ing differences in experiences could be captured. However, that three next of kin 
came from the same family might limit the study’s external validity.
The ICF was in the present thesis used as a conceptual framework, primarily 
when designing studies and when choosing measures to be used to describe and 
explore disability and contextual factors in patients with ALS and their next of 
kin. Even though the ICF provides a framework for obtaining a coherent view of 
health, it lacks a reference to HRQL, which is needed for a comprehensive view. 
Thus, HRQL measures were used in addition to the selected measures covering 
the different components of the ICF.
Studies I and III used cross-sectional designs, which are useful when studying the 
occurrence and severity of, e.g., health problems. Although this design is applicable 
for studying relationships, it cannot with certainty explain cause-effect relations 
(183). Study II used a prospective observational design, as the aim was to perform 
repeated observations of the same variables in patients with ALS over a three-
year period. Study IV used a qualitative design, as the aim was to gain insight 
into experiences of next of kin to patients with ALS undergoing TIV. Qualitative 
designs are useful when the aim is to learn from participants why and how they 
experience a situation, process or setting, as well as the meaning and interpreta-
tion of their experiences. 
Most data used in the present thesis were collected during home visits. This method 
was chosen because it was previously used successfully in other neurological 
cohorts (47, 184, 185). The home visits were much appreciated by the participat-
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ing patients with ALS and contributed to high patient compliance during data 
collections. It was an advantage to interview participants, patients and next of 
kin in their own environment, as it empowered them, and that detailed informa-
tion could be obtained in a way not possible during a hospital visit or via a postal 
survey. Further, it can be argued that this method provides ecological validity, as 
the real-world was studied.
The selection of measures used in the present thesis was based on previous  knowledge 
and experience, literature reviewing, and reported psychometric properties. There 
was, however, a lack of measures evaluated concerning validity, reliability and 
responsiveness in the ALS population. This might be considered a limitation, but 
it is not unusual in the study of rare diseases. The self-reported questionnaires that 
were used, however, were standardized and well-known in the clinical settings 
and in the research context, and psychometric properties had been evaluated in 
the general population or in people with other neurological diseases. Even though 
the MoCA has previously been used in studies of patients with ALS (186, 187), 
it had obvious shortcomings, as most patients could not complete all parts of the 
assessment. Like many other cognitive tests, the MoCA relies on patients’ physi-
cal abilities (pen-and-paper items), which makes it less useful in ALS. Another 
example of a questionnaire based on physical abilities and performance is the FAI. 
This questionnaire, which was used to map the frequency of social and lifestyle 
activities among the patients, was developed before the use of internet with its 
possibilities for, e.g., social interaction or shopping. Thus, the findings on partici-
pation restrictions should be interpreted with some caution, as patients might use 
technology to compensate for lack of physical performance. 
The well-known and generic measure SIP was used as a measure of HRQL in 
patients with ALS. Although SIP can be criticized for having many items, it 
is rather easy for patients to complete, as they only need to answer yes or no. 
Furthermore, the questionnaire has previously been used in patients with other 
neurological diseases (47, 184, 185, 188, 189). SIP was, however, considered 
less suitable for next of kin, as it evaluates the impact of disease. Another generic 
HRQL measure, the SF-36, was therefore chosen for next of kin. In addition to 
these standardized questionnaires, the EQ-VAS was used. The EQ-VAS provides 
important, complementary information on individuals’ views about their HRQL. 
It can be argued that the EQ-VAS has some important advantages when the indi-
viduals’ views are paramount. 
Although patients were recruited from the Karolinska University Hospital’s ALS 
clinic, a major clinic in Sweden, the study sample had considerably reduced 
already after one year. This hampered the possibility for longitudinal analyses, 
such as repeated measures analysis, and descriptive statistics was therefore used 
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to present the available data at each time point. Cross-sectional data were used 
in analyses of factors associated with HRQL, in both patients with ALS and their 
next of kin. Even though the cause-effect relationship cannot be established, it is 
likely that the associated factors influenced HRQL and not the other way around. 
For example, it is more likely that disease severity influenced HRQL rather than 
that HRQL had an impact on the disease. Interestingly, the explained variance in 
the multivariate regression analyses was generally considerably higher when the 
dependent variable was the SIP or SF-36 compared to when the EQ-VAS was 
used. This highlights the value of using complementary measures, and further 
that anamnestic information is needed to understand what is important for the 
individual patient or next of kin.
Content analysis with an inductive approach was used in Study IV, a method con-
sidered useful for investigating both individual experiences and the wholeness of 
being next of kin. That the interviews were performed by two data collectors, one 
of whom led the interview and the other followed up on important matters, was a 
strength and probably enrichened the interviews. Furthermore, the trustworthiness 
of the results was increased by the frequent discussions between the authors in 
the process of analysis. 
5.7 Conclusions and clinical implications
Regardless of disease severity, fatigue, anxiety, depression and pain were com-
monly and concurrently present in patients with ALS. Furthermore, activity limi-
tations and participation restrictions were frequently reported. Factors associated 
with patients’ HRQL were identified. Some of these factors are amenable to health 
care interventions; e.g. fatigue, anxiety and depression, and others might serve as 
“red flags” for health care, i.e. that these patients might need extra care and sup-
port, e.g. patients with low coping capacity. The results indicate that patients with 
ALS need to be regularly screened for commonly present impairments, activity 
limitations, participation restrictions and perceived HRQL, so that person-centred 
interventions can be applied at the right time. 
Positive and negative experiences of caregiving were reported by the next of kin 
who all served as informal caregivers. Factors associated with the informal care-
givers’ HRQL and life satisfaction were identified. As for patients with ALS, some 
of the identified factors might be amenable to health care interventions, and others 
can serve as “red flags” for health care, e.g. that younger caregivers, men, and 
those who cohabit with the patient might need extra support and services. Next of 
kin to patients undergoing TIV described the care process related to TIV as tur-
bulent, that their everyday life was strained, and that they perceived a conflict in 
being next of kin and a formal caregiver. Taken together, the results indicate that 
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health care should support and promote positive aspects of caregiving, provide 
services and support to reduce negative caregiving experiences, and to consider 
the individual next of kin/ informal caregivers’ experience and involve them when 
planning care, service and support.
5.8 Future studies
Besides being a frequently occurring impairment in ALS, fatigue was also associated 
with patients’ HRQL. The phenomenon of fatigue is complex, with both physio-
logical and psychological dimensions, and there is a lack of research exploring 
these dimensions in the ALS population. Further, few studies have investigated 
interventions aiming to reduce fatigue. Thus, future studies are required to explore 
the fatigue phenomenon in ALS, and to develop and evaluate treatment strategies. 
Although not present in the majority, there was a fair number of patients being 
categorized as having possible or probable anxiety and/or depression at each time-
point. Anxiety and/or depression in patients with ALS was also associated with 
informal caregivers’ HRQL. Most published studies have explored the prevalence 
of these impairments in the ALS population, and few have evaluated effects of 
interventions. Future studies are therefore needed to monitor the effectiveness of 
pharmacological treatments and to evaluate the effects of non-pharmacological 
interventions, e.g. cognitive behavioural therapy, mindfulness or meditation. In 
addition, future studies should also evaluate combinations of pharmacological and 
non-pharmacological treatments.
Pain has been described as a largely neglected impairment in patients with ALS. 
The results showed that approximately half of the patients reported pain at each 
timepoint. Previous studies have mainly focused on the prevalence of pain, and 
thus, there is a need for future studies on the pathophysiology of pain and the 
effectiveness of treatment strategies.
ALS is a disease that impacts the patients’ life as well as the life of their next of 
kin. Most literature in the past has focused on describing caregiver burden among 
next of kin and their need for care, service and support. There appears to be a lack 
of studies describing how this care and support should be delivered and organized. 
It would therefore be interesting in the future to study whether a self-management 
program, developed in a co-design process where next of kin and health profes-
sionals take an equal role in the development, could be beneficial for the next of 
kin to patients with ALS.
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